相关实验视频

Updated: Sep 15, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌中的miR-184:一个有前途的治疗点

Leila Hosseinzadeh¹, Fereshteh Jalilian¹, Mohammad Reza Kalhori²

¹Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Journal of physiology and biochemistry

|July 16, 2025

概括

微RNA-184 (miR-184) 在肝细胞癌 (HCC) 中起着双重作用,同时起到瘤基因和瘤抑制作用. 它的失调会影响HCC的进展,并具有作为诊断生物标志物的潜力.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
生物化学生物化学

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
微RNAs (miRNAs) 调节基因表达,并参与癌症的发展.
miR-184已被确定为各种癌症的关键参与者.

研究的目的:

研究miR-184在肝细胞癌 (HCC) 中的特定作用和调节机制.
探索miR-184作为HCC的诊断和预后生物标志物的潜力.

主要方法:

在HCC组织和相邻的正常组织中分析miR-184表达.
识别miR-184目标基因和受影响的信号通路 (例如,Wnt/β-catenin,JAK2/STAT3/AKT).
研究miR-184与非编码RNA (circRNA, lncRNA) 之间的调控相互作用.

主要成果:

miR-184在HCC中表现出双重致癌和瘤抑制功能,这取决于其向基因.
失调的miR-184表达与HCC中增加的增殖,减少的亡和抑制的自相关.
在HCC组织和血液中,miR-184的表达发生了变化,这表明生物标记物的潜力.
涉及circRNAs和lncRNAs的复杂调节网络调节miR-184活动.

结论:

miR-184是HCC中的关键调节剂,影响关键的细胞过程和信号通路.
改变的miR-184水平表明它有可能成为HCC的诊断和预后生物标志物.
向miR-184及其调节性非编码RNAs为HCC提供了一个有前途的治疗策略.

关键词:

生物标志物生物标志物肝细胞癌是肝细胞癌.瘤基因是一种瘤基因.瘤抑制基因的基因在 miR-184 中,它是最常见的.

更多相关视频

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...